NFE2L2 and melanoma: Khamari and colleagues also demonstrated that BRAFi-resistant melanoma displays a robust activation of Nrf2 and consequent metabolic modifications that induce an increase in glutathione level that, in turn, promotes the intracellular redox balance that allows for the survival of BRAFi-resistant melanoma cells [162].